Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C19H21NO4 |
Molecular Weight | 327.3743 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 1 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[H][C@]12CC3=CC(O)=C(OC)C=C3C4=C1C(CCN2C)=CC(O)=C4OC
InChI
InChIKey=LZJRNLRASBVRRX-ZDUSSCGKSA-N
InChI=1S/C19H21NO4/c1-20-5-4-10-7-15(22)19(24-3)18-12-9-16(23-2)14(21)8-11(12)6-13(20)17(10)18/h7-9,13,21-22H,4-6H2,1-3H3/t13-/m0/s1
Molecular Formula | C19H21NO4 |
Molecular Weight | 327.3743 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 1 / 1 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Boldine, an aporphine alkaloid, found abundantly in the leaves/bark of boldo (Peumus boldus Molina) widely consumed in the folk medicine of some regions. Boldine possesses various pharmacological properties including, anticancer activity. It exhibits a significant improvement of learning and memory through inhibition of brain acetylcholinesterase activity and alleviation of brain oxidative stress, which was shown on animal models. Boldine is a potentially useful agent for the treatment of leishmaniosis. In addition, it suppresses osteoclastogenesis, improves bone destruction and may be a potential therapeutic agent for rheumatoid arthritis. Besides, was shown, that boldine inhibits telomerase in cells treated with sub-cytotoxic concentrations. Telomerase inhibition occurs via down-regulation of human telomerase reverse transcriptase (hTERT), the catalytic subunit of the enzyme.
CNS Activity
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: P22303|||Q53F46 Gene ID: 43.0 Gene Symbol: ACHE Target Organism: Homo sapiens (Human) Sources: https://www.ncbi.nlm.nih.gov/pubmed/29136766 |
|||
Target ID: O14746 Gene ID: 7015.0 Gene Symbol: TERT Target Organism: Homo sapiens (Human) Sources: https://www.ncbi.nlm.nih.gov/pubmed/25746354 |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Primary | Unknown Approved UseUnknown |
|||
Primary | Unknown Approved UseUnknown |
|||
Primary | Unknown Approved UseUnknown |
PubMed
Title | Date | PubMed |
---|---|---|
Screening for new compounds with antiherpes activity. | 1984 Oct |
|
Antipoliovirus structure-activity relationships of some aporphine alkaloids. | 1998 Apr |
|
Halogenated boldine derivatives with enhanced monoamine receptor selectivity. | 2000 Apr |
|
Protective effect of boldine on dopamine-induced membrane permeability transition in brain mitochondria and viability loss in PC12 cells. | 2002 Feb 1 |
|
Free-radical scavengers and antioxidants from Peumus boldus Mol. ("Boldo"). | 2003 Apr |
|
Spectroscopic study of antileishmanial drug incubated in the promastigotes of Leishmania mexicana. | 2003 Nov |
|
A novel alkaloid antioxidant, Boldine and synthetic antioxidant, reduced form of RU486, inhibit the oxidation of LDL in-vitro and atherosclerosis in vivo in LDLR(-/-) mice. | 2004 Apr |
|
[Alkaloids from the root of Lindera angustifolia]. | 2005 Oct |
|
Boldine and its antioxidant or health-promoting properties. | 2006 Jan 5 |
|
Are extraction methods in quantitative assays of pharmacopoeia monographs exhaustive? A comparison with pressurized liquid extraction. | 2006 Oct |
|
Simultaneous determination of four alkaloids in Lindera aggregata by ultra-high-pressure liquid chromatography-tandem mass spectrometry. | 2008 Nov 28 |
|
Boldine: a potential new antiproliferative drug against glioma cell lines. | 2009 Dec |
|
5-Hydroxytryptamine2A receptor binding activity of compounds from Litsea sessilis. | 2009 Mar |
|
Grandine A, a new proaporphine alkaloid from the bark of Phoebe grandis. | 2009 Mar 23 |
|
Direct identification of phenolic constituents in Boldo Folium (Peumus boldus Mol.) infusions by high-performance liquid chromatography with diode array detection and electrospray ionization tandem mass spectrometry. | 2010 Jan 22 |
|
Current and developing therapeutic agents in the treatment of Chagas disease. | 2010 Sep 24 |
|
Boldine, a natural aporphine alkaloid, inhibits telomerase at non-toxic concentrations. | 2015 Apr 25 |
|
Boldine enhances bile production in rats via osmotic and farnesoid X receptor dependent mechanisms. | 2015 May 15 |
Sample Use Guides
in mice: boldine (1.5, 3 and 6mg/kg, po) for 7 successive days exhibited significant improvement of learning and memory of young and aged mice
anticonvulsant effects in mice: boldine (once in a day for 8 days, ip.)
in mice: repeated i. p. injections of 30, 60, or 90 mg boldine/kg slowed tumor growth
Route of Administration:
Other
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/28719960
It was shown that boldine is a potentially useful agent for the treatment of leishmaniasis. The in vitro system consisted of murine macrophage infection with amastigotes of L. amazonensis treated with different concentrations from 50 to 600 μg/ml of boldine for 24 hr. Intracellular parasite destruction was assessed by morphological examination and boldine cytotoxicity to macrophages was tested by the MTT viability assay. When cells were treated with 100 μg/ml of boldine the reduction of parasite infection was 81% compared with untreated cultures cells.
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 18:36:57 GMT 2023
by
admin
on
Fri Dec 15 18:36:57 GMT 2023
|
Record UNII |
8I91GE2769
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
EU-Orphan Drug |
EU/3/13/1226
Created by
admin on Fri Dec 15 18:36:57 GMT 2023 , Edited by admin on Fri Dec 15 18:36:57 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
DTXSID40883394
Created by
admin on Fri Dec 15 18:36:57 GMT 2023 , Edited by admin on Fri Dec 15 18:36:57 GMT 2023
|
PRIMARY | |||
|
207-509-9
Created by
admin on Fri Dec 15 18:36:57 GMT 2023 , Edited by admin on Fri Dec 15 18:36:57 GMT 2023
|
PRIMARY | |||
|
SUB13107MIG
Created by
admin on Fri Dec 15 18:36:57 GMT 2023 , Edited by admin on Fri Dec 15 18:36:57 GMT 2023
|
PRIMARY | |||
|
10154
Created by
admin on Fri Dec 15 18:36:57 GMT 2023 , Edited by admin on Fri Dec 15 18:36:57 GMT 2023
|
PRIMARY | |||
|
65689
Created by
admin on Fri Dec 15 18:36:57 GMT 2023 , Edited by admin on Fri Dec 15 18:36:57 GMT 2023
|
PRIMARY | |||
|
100000076875
Created by
admin on Fri Dec 15 18:36:57 GMT 2023 , Edited by admin on Fri Dec 15 18:36:57 GMT 2023
|
PRIMARY | |||
|
8I91GE2769
Created by
admin on Fri Dec 15 18:36:57 GMT 2023 , Edited by admin on Fri Dec 15 18:36:57 GMT 2023
|
PRIMARY | |||
|
BOLDINE
Created by
admin on Fri Dec 15 18:36:57 GMT 2023 , Edited by admin on Fri Dec 15 18:36:57 GMT 2023
|
PRIMARY | |||
|
m2598
Created by
admin on Fri Dec 15 18:36:57 GMT 2023 , Edited by admin on Fri Dec 15 18:36:57 GMT 2023
|
PRIMARY | Merck Index | ||
|
476-70-0
Created by
admin on Fri Dec 15 18:36:57 GMT 2023 , Edited by admin on Fri Dec 15 18:36:57 GMT 2023
|
PRIMARY | |||
|
C011686
Created by
admin on Fri Dec 15 18:36:57 GMT 2023 , Edited by admin on Fri Dec 15 18:36:57 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> CONSTITUENT ALWAYS PRESENT |